High-dose daptomycin in documented Staphylococcus aureus infections.
about
Daptomycin: an evidence-based review of its role in the treatment of Gram-positive infectionsSafety profiles of old and new antimicrobials for the treatment of MRSA infections.Safety and efficacy of high-dose daptomycin as salvage therapy for severe gram-positive bacterial sepsis in hospitalized adult patientsCutaneous infections and infestations: new therapiesHigh-dose daptomycin therapy for staphylococcal endocarditis and when to apply it.Evaluation of Effectiveness and Safety of High-Dose Daptomycin: Results from Patients Included in the European Cubicin(®) Outcomes Registry and Experience.Antimicrobial Stewardship Intervention and Feedback to Infectious Disease Specialists: A Case Study in High-Dose Daptomycin.A survey on infection management practices in Italian ICUsBloodstream infections in the Intensive Care Unit.High-dose, short-interval daptomycin regimen was safe and well tolerated in three patients with chronic renal failure.Daptomycin dosing based on ideal body weight versus actual body weight: comparison of clinical outcomes.When sepsis persists: a review of MRSA bacteraemia salvage therapy.Daptomycin use: where is the truth? Authors' response.Daptomycin Pharmacokinetics and Pharmacodynamics in Septic and Critically Ill Patients.A combination of ceftaroline and daptomycin has synergistic and bactericidal activity in vitro against daptomycin nonsusceptible methicillin-resistant Staphylococcus aureus (MRSA).Study on daptomycin use and implementation of an antimicrobial stewardship program.Successful salvage therapy with Daptomycin for osteomyelitis caused by methicillin-resistant Staphylococcus aureus in a renal transplant recipient with Fabry-Anderson disease.Risk factors associated with the onset of daptomycin non-susceptibility in Staphylococcus aureus infections in critically ill patients.Association of Higher Daptomycin Dose (7 mg/kg or Greater) with Improved Survival in Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia.Is empiric daptomycin effective in reducing mortality in Staphylococcus aureus bacteraemia? A real-life experience.Daptomycin versus teicoplanin for bloodstream infection due to methicillin-resistant Staphylococcus aureus with a high teicoplanin minimal inhibitory concentration ≥1.5 mg/L: a propensity score-based analysis
P2860
Q26752922-E8CDE984-3766-4AEA-A3BD-CD5E1EBA9E05Q33429168-F416ECE1-B759-402B-A29A-5F382C64DAEBQ34573702-621B3687-BBD8-474F-8833-2F410BA97B33Q35628618-3F89A8AF-3AB8-439F-B2A3-27BBA5CB7330Q35848781-DA7A4792-368A-48AC-B2E8-3101D781ED28Q36373724-C6B9EE4C-8251-4A2B-A71C-9A4B61C0C2E7Q36683458-6990604D-D1D0-4524-867B-FB9774FC8284Q36902763-66B50E5D-449A-4FD7-8202-17578550C477Q36913336-F634878B-36D8-4D88-9F5C-EA430212705CQ37291084-63ABD67E-D905-4641-8655-74D7232D986DQ37544510-F5DE0B28-49EA-41C0-A2FA-1F4F4DB13DD0Q38632488-1294FA74-1132-48B7-9FFC-753DB200ECE8Q38786608-D57ADC4F-8576-40C5-B847-DB6B7A5BD6AFQ38895642-C77750A7-7124-409E-A9C5-BF55D21259BBQ40360449-F1DF64C0-686A-4A6B-B946-2C34CF1865B1Q40764649-7CA74BB0-ACB6-4604-B4C0-9037FEF56DA3Q41858729-D8DA6E10-85CD-497C-96E4-1DF2FD11BDACQ43949662-FA4215BD-5E32-429D-8088-D30A0E82D365Q47318913-E8339A1A-A173-4BB3-B4BF-6DAB8117B6FEQ54785836-297F6FD4-2A2E-4C06-9A93-16641A63C2D5Q59135465-205E1330-84E7-4351-B287-18DF38141A35
P2860
High-dose daptomycin in documented Staphylococcus aureus infections.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
High-dose daptomycin in documented Staphylococcus aureus infections.
@en
High-dose daptomycin in documented Staphylococcus aureus infections.
@nl
type
label
High-dose daptomycin in documented Staphylococcus aureus infections.
@en
High-dose daptomycin in documented Staphylococcus aureus infections.
@nl
prefLabel
High-dose daptomycin in documented Staphylococcus aureus infections.
@en
High-dose daptomycin in documented Staphylococcus aureus infections.
@nl
P2093
P1476
High-dose daptomycin in documented Staphylococcus aureus infections.
@en
P2093
Claudio Viscoli
Daniela de Florentiis
Elena Nicco
Filippo Ansaldi
Francesca Ginocchio
Matteo Bassetti
P304
P356
10.1016/J.IJANTIMICAG.2010.07.011
P577
2010-09-16T00:00:00Z